Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Two molecular pathways to transitional cell carcinoma of the bladder.

Spruck CH 3rd, Ohneseit PF, Gonzalez-Zulueta M, Esrig D, Miyao N, Tsai YC, Lerner SP, Schm├╝tte C, Yang AS, Cote R, et al.

Cancer Res. 1994 Feb 1;54(3):784-8.

2.

Genetic and molecular markers of urothelial premalignancy and malignancy.

Cordon-Cardo C, Cote RJ, Sauter G.

Scand J Urol Nephrol Suppl. 2000;(205):82-93. Review.

PMID:
11144907
3.

Molecular alterations associated with bladder cancer initiation and progression.

Cordon-Cardo C.

Scand J Urol Nephrol Suppl. 2008 Sep;(218):154-65. doi: 10.1080/03008880802291915. Review.

PMID:
18815930
4.

Molecular and kinetic features of transitional cell carcinomas of the bladder: biological and clinical implications.

Baithun SI, Naase M, Blanes A, Diaz-Cano SJ.

Virchows Arch. 2001 Mar;438(3):289-97. Review.

PMID:
11315626
5.

The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.

Smith ND, Rubenstein JN, Eggener SE, Kozlowski JM.

J Urol. 2003 Apr;169(4):1219-28. Review.

PMID:
12629332
6.

[Molecular changes in development and progression of urothelial carcinoma].

Hartmann A.

Verh Dtsch Ges Pathol. 2003;87:172-84. Review. German.

PMID:
16888910
7.

Bladder cancer.

Ozen H.

Curr Opin Oncol. 1998 May;10(3):273-8. Review.

PMID:
9619365
8.

[Tracking the gatekeeper gene in the stages of carcinogenesis in the bladder].

Baud E, Catilina P, Bignon YJ.

Bull Cancer. 1997 Oct;84(10):971-5. Review. French.

9.

[Genomic changes in urinary bladder cancer].

Sauter G, Moch H, Wagner U, Bubendorf L, Gasser TC, Mihatsch MJ.

Verh Dtsch Ges Pathol. 1997;81:287-96. Review. German.

PMID:
9474882
10.

Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer.

Wolff EM, Liang G, Jones PA.

Nat Clin Pract Urol. 2005 Oct;2(10):502-10. Review.

PMID:
16474624
11.

p53 and chemosensitivity in bladder cancer.

Nishiyama H, Watanabe J, Ogawa O.

Int J Clin Oncol. 2008 Aug;13(4):282-6. doi: 10.1007/s10147-008-0815-x. Epub 2008 Aug 15. Review.

PMID:
18704627
12.

Bladder cancer.

Ozen H.

Curr Opin Oncol. 1996 May;8(3):259-63. Review.

PMID:
8794154
13.

Molecular pathways of urothelial development and bladder tumorigenesis.

Castillo-Martin M, Domingo-Domenech J, Karni-Schmidt O, Matos T, Cordon-Cardo C.

Urol Oncol. 2010 Jul-Aug;28(4):401-8. doi: 10.1016/j.urolonc.2009.04.019. Review.

PMID:
20610278
14.

Molecular pathogenesis of bladder cancer.

Knowles MA.

Int J Clin Oncol. 2008 Aug;13(4):287-97. doi: 10.1007/s10147-008-0812-0. Epub 2008 Aug 15. Review.

PMID:
18704628
15.

[Familial bladder cancer].

Terai A.

Nihon Rinsho. 1995 Nov;53(11):2749-53. Review. Japanese.

PMID:
8538038
16.

Genetics of transitional cell carcinoma.

Klein EA, Chaganti RS.

Semin Surg Oncol. 1992 Sep-Oct;8(5):260-6. Review.

PMID:
1462095
17.

Molecular genetics of human bladder carcinomas.

Perucca D, Szepetowski P, Simon MP, Gaudray P.

Cancer Genet Cytogenet. 1990 Oct 15;49(2):143-56. Review.

PMID:
2208052
18.

Classification and grading of the non-invasive urothelial neoplasms: recent advances and controversies.

Montironi R, Lopez-Beltran A, Mazzucchelli R, Bostwick DG.

J Clin Pathol. 2003 Feb;56(2):91-5. Review.

19.

Pathology of superficial bladder cancer with emphasis on carcinoma in situ.

Weinstein RS, Coon JS, Schwartz D, Miller AW 3rd, Pauli BU.

Urology. 1985 Oct;26(4 Suppl):2-10. Review.

PMID:
3901485
20.

Chromosomal analysis of bladder cancer. III. Nonrandom alterations.

Smeets W, Pauwels R, Laarakkers L, Debruyne F, Geraedts J.

Cancer Genet Cytogenet. 1987 Nov;29(1):29-41. Review.

PMID:
3311350

Supplemental Content

Support Center